US 11591341
Bicyclic and tricyclic compounds
granted A61KA61K31/4985A61K31/551
Quick answer
US patent 11591341 (Bicyclic and tricyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4985, A61K31/551, A61K31/675, A61K31/683